List of insiders holdings for Aprea Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| HealthCap VII L.P. HealthCap VII GP S.A. 10% Owner | 2022-11-15 17:08:05 | 2,366,104 0 | 2,366,104 | Form 13D |
| KDev Investments AB Karolinska Development AB KCIF Co-Investment Fund KB 10% Owner | 2021-02-16 06:51:58 | 1,780,691 0 | 1,780,691 | Form 13G |
| 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder | 2021-02-16 17:08:15 | 619,157 0 | 619,157 | Form 13D |
| Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2020-05-20 21:58:59 | 333,333 6,968 | 340,301 | Form 4 |
| Gilad Oren President/CEO | 2024-10-24 08:30:13 | 333,395 1,800 | 335,195 | Form 4 |
| SCHADE CHRISTIAN S Director | 2022-08-01 17:06:17 | 306,846 11,000 | 317,846 | Form 4 |
| Coiante Scott M SVP, Chief Financial Officer | 2022-08-01 17:00:42 | 234,265 0 | 234,265 | Form 4 |
| Duey Marc Director | 2024-10-25 17:42:04 | 233,651 602 | 234,253 | Form 4 |
| Abrahmsen Lars B. SVP, Chief Scientific Officer | 2022-03-14 17:01:04 | 143,700 0 | 143,700 | Form 4 |
| Wessels Gregory S. SVP, Chief Commercial Officer | 2021-03-01 19:10:17 | 82,000 0 | 82,000 | Form 4 |
| Korbel Gregory Alan SVP, Chief Operating Officer | 2022-08-01 17:04:13 | 81,462 0 | 81,462 | Form 4 |
| Attar Eyal C. SVP, Chief Medical Officer | 2022-06-07 17:00:32 | 57,233 331 | 57,564 | Form 4 |
| Seizinger Bernd R. Director | 2024-10-15 08:31:44 | 44,730 0 | 44,730 | Form 4 |
| Mirza Nadeem Q. Chief Medical Officer | 2024-05-02 16:16:29 | 33,650 0 | 33,650 | Form 4 |
| Namouni Fouad Director | 2021-07-01 18:58:01 | 27,360 0 | 27,360 | Form 4 |
| Kelly Michael Aaron Director | 2021-07-01 19:07:34 | 27,360 0 | 27,360 | Form 4 |
| Pamukcu Rifat Director | 2024-06-21 16:19:20 | 8,586 14,108 | 22,694 | Form 4 |
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2024-10-16 08:30:13 | 19,368 0 | 19,368 | Form 4 |
| HENNEMAN JOHN B III Director | 2024-06-21 16:17:29 | 13,369 0 | 13,369 | Form 4 |
| Gruia Gabriela Director | 2023-05-08 17:17:19 | 12,500 0 | 12,500 | Form 4 |
| BIZZARI JEAN-PIERRE Director | 2023-08-24 21:47:00 | 12,500 0 | 12,500 | Form 4 |
| Magni Guido Director | 2019-10-07 19:25:54 | 6,500 0 | 6,500 | Form 4 |
| Peters Richard Director | 2024-06-21 16:18:13 | 6,259 0 | 6,259 | Form 4 |
| Grissinger Michael Director | 2024-06-21 16:16:34 | 6,029 0 | 6,029 | Form 4 |
| Hepple Jonathan Director | 2020-07-01 18:03:19 | 5,600 0 | 5,600 | Form 4 |
| Christenson Johan Director | 2020-07-01 18:01:06 | 5,600 0 | 5,600 | Form 4 |
| Redmile Group LLC Green Jeremy 10% Owner | 2022-02-14 17:07:14 | 0 0 | 0 | Form 13G |
| Versant V Luxco S.a r.l. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner | 2022-02-10 20:44:54 | 0 0 | 0 | Form 13G |
| Versant V Luxco S.a r.l. Versant Ventures V LLC Versant Ventures V GP-GP (Canada) Inc. Versant Ventures V (Canada) L.P. Versant Venture Capital V (Canada) LP Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V L.P. 10% Owner | 2022-02-10 20:44:54 | 0 0 | 0 | Form 13G |